Oxidative stress in the brain causes hypertension via sympathoexcitation

Frontiers in Physiology

Volumn 3 AUG, Issue , 2012, Pages

  Kishi, Takuya ^a   Hirooka, Yoshitaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Brain; Hypertension; Oxidative stress; Sympathetic nerve activity

Indexed keywords

EID: 84866497986     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00335     Document Type: Review

References (128)

1. Adams, J. M., Madden, C. J., Sved, A. F., and Stocker, S. D. (2007). Increased dietary salt enhances sym-pathoexcitatory and sympathoin-hibitory responses from the rostral ventrolateral medulla. Hypertension 50, 354-359.
2. Adrogue, H. J., and Madias, N. E. (2007). Sodium and potassium in the pathogenesis of hypertension. N. Engl. J. Med. 356, 1966-1978.
3. Allen, A. M., MacGregor, D. P., McKinley, M. J., and Mendelsohn, E A. O. (1999). Angiotensin II receptors in the human brain. Regul. Pept. 79, 1-7.
4. Araki, S., Hirooka, Y., Kishi, T., Yasukawa, K., Utsumi, H., and Sunagawa, K. (2009). Olmesartan reduces stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method. Hypertens. Res. 32, 1091-1096.
5. Bai, Y., Jabbari, B., Ye, S., Campese, V. M., and Vaziri, N. D. (2009). Regional expression of NAD(P)Hoxidase and superoxide dismutase in the brain of rats with neurogenic hypertension. Am. J. Nephrol. 29, 483-492.
6. Briones, A. M., and Touyz, R. M. (2010). Oxidative stress and hypertension: current concepts. Curr. Hypertens. Rep. 12, 135-142.
7. Brooks, V. L., Haywood, J. R., and Johnson, A. K. (2005). Translation of salt retention to central activation of the sympathetic nervous system in hypertension. Clin. Exp. Pharmacol. Physiol. 32, 426-432.
8. Calaresu, E R., and Ciriello, J. (1981). Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in cat. J. Auton. Nerv. Syst. 3, 311-320.
9. Campese, V. M., Shaohua, Y., and Huiquin, Z. (2005). Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46, 533-539.
10. Campese, V. M., Sindhu, R. K., Ye, S., Bai, Y., Vaziri, N. D., and Jabbari, B. (2007). Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res. 1134,27-32.
11. Campos, R. R. (2009). Oxidative stress in the brain and arterial hypertension. Hypertens. Res. 32, 1047-1048.
12. Campos, R. R., and Bergamschi, C. T. (2006). Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr. Hypertens. Rev. 2, 193-198.
13. Cardinale, J. P., Sriramula, S., Mariappan, N., Agarwal, D., and Francis, J. (2011). Angiotensin II-induced hypertension hypertension is modulated by nuclear factor-kB in the paraventricular nucleus. Hypertension 59, 113-121.
14. Carlson, S. H., and Wyss, J. M. (2008). Neurohormonal regulation of the sympathetic nervous system: new insights into central mechanisms of action. Curr. Hypertens. Rep. 10, 233-240.
15. Chan, S. H. H., Hsu, K. S., Huang, C. C., Wang, L. L., Ou, C. C., and Chan, J. Y. H. (2005). NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ. Res. 97, 772-780.
16. Chan, S. H. H., Wang, L. L., Tseng, H. L., and Chan, J. Y. H. (2007). Upregulation of AT1 receptor gene on activation of protein kinase Cb/nicotinamide adenine dinu-cleotide disphosphate oxidase/ ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J. Hypertens. 25, 1845-1861.
17. Chan, S. H. H., Wu, K. L. H., Chang, A. Y. W., Tai, M. H., and Chan, J. Y. H. (2009). Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neu-rogenic hypertension. Hypertension 53,217-227.
18. Ciriello, J., and Calaresu, F. R. (1983). Central projection of afferent renal fibers in the rat: an antegrade transport study of horseradish per-oxidase. J. Auton. Nerv. Syst. 8, 273-285.
19. Coote, J. H. (2007). Landmarks in understanding the central nervous control of the cardiovascular system. Exp. Physiol. 92, 3-18.
20. Dampney, R. A. L. (1994). Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 74, 323-364.
21. Dampney, R. A. L., Horiuchi, J., Killinger, S., Sheriff, M. J., Tan, P. S. P., and McDowall, L. M. (2005). Long-term regulation of arterial blood pressure by hypotha-lamic nuclei: some critical questions. Clin. Exp. Pharmacol. Physiol. 32,419-425.
22. Dampney, R. A. L., Polson, J. W., Potts, P. D., Hirooka, Y., and Horiuchi, J. (2003). Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression. Cell. Mol. Neurobiol. 23, 597-616.
23. Dampney, R. A. L., Tan, P. S. P., Sheriff, M. J., Fontes, M. A. P., and Horiuchi, J. (2007). Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr. Hypertens. Rep. 9, 222-227.
24. DiBona, G. F., and Esler, M. (2010). Translational medicine: the antihypertensive effect of renal denervation. Am. J. Physiol. 298, R245-R253.
25. Dupont, A. G., and Brouwers, S. (2010). Brain angiotensin peptides regulate sympathetic tone and blood pressure.J. Hypertens. 28, 1599-1610.
26. Esler, M. (2010). The 2009 Carl Ludwig lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J. Appl. Physiol. 108, 227-237.
27. Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., and Lambert, E. (2006). Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796.
28. Fujita, M., Ando, K., Nagae, A., and Fujita, T. (2007). Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50, 360-367.
29. Gao, L., Wang, W., Li, Y. L., Schultz, H. D., Liu, D., Cornish, K. G., and Zucker, I. H. (2005). Simvastatin therapy normalizes sympathetic neural control in experimental heart failure. Circulation 112, 1763-1770.
30. Garthwaite, J. (2008). Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 27,2783-2802.
31. Gohlke, P., Weiss, S., Jansen, A., Wienen, W., Stangier, J., Rascher, W., Culman, J., and Unger, T. (2001). AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J. Pharmacol. Exp. Ther. 298, 62-70.
32. Golomb, B. A., Dimsdale, J. E., White, H. L., Ritchie, J. B., and Criqui, M. H. (2008). Reduction in blood pressure with statins: results from the USCD statin study, a randomized trial. Arch. Intern. Med. 168, 721-727.
33. Gomes, M. E., Tack, C. J., Verheugt, F. W., Smiths, P., and Lenders, J. W. M. (2010). Sympathoinhibition by atorvastatin in hypertensive patients. Circ. J. 74, 2622-2626.
34. Grassi, G. (2006). Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens. Res. 29, 839-847.
35. Grassi, G. (2007). Adrenergic overdrive as the link among hypertension, obesity, and impairedthermo-genesis: lights and shadows. Hypertension 49, 5-6.
36. Grassi, G. (2009). Assessment of sympathetic cardiovascular drive in human hypertension:achievements and perspectives. Hypertension 54, 690-697.
37. Grassi, G. (2010). Sympathetic neural activity in human hypertension and related diseases. Am. J. Hypertens. 23, 1052-1060.
38. Grassi, G., Seravalle, G., and Quarti-Trevano, F. (2010). The 'neurogenic hypothesis' in hypertension: current evidence. Exp. Physiol. 95, 581-586.
39. Guyenet, P. G. (2006). The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7, 335-346.
40. Hilzendeger, A. M., Morgan, D. A., Brooks, L., Dellsperger, D., Liu, X., Grobe, J. L., Raumouni, K., Sigmund, C. D., and Mark, A. L. (2012). A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am. J. Physiol. 302, H197-H206.
41. Hirooka, Y (2008). Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton. Neurosci. 142, 20-24.
42. Hirooka, Y (2010). Brain perivascu-lar macrophages and central sympathetic activation after myocardial infarction: heart and brain interaction. Hypertension 55, 610-611.
43. Hirooka, Y (2011). Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension. Hypertens. Res. 34, 407-412.
44. Hirooka, Y., Kimura, Y., Nozoe, M., Sagara, Y., Ito, K., and Sunagawa, K. (2006). Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hypertens. Res. 29, 49-56.
45. Hirooka, Y., Kishi, T., Sakai, K., Shimokawa, H., and Takeshita, A. (2003). Effects of overproduction of nitric oxide in the brain stem on the cardiovascular response in conscious rats. J. Cardiovasc. Pharmacol 41(Suppl 1), S119-S126.
46. Hirooka, Y., Kishi, T., Sakai, K., Takeshita, A., and Sunagawa, K. (2011). Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am. J. Physiol. 300, R818-R826.
47. Hirooka, Y., Potts, P. D., and Dampney, R. A. L. (1997). Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla. Brain Res. 772,107-114.
48. Hirooka, Y., Sagara, Y., Kishi, T., and Sunagawa, K. (2010). Oxidative stress and central cardiovascular regulation: pathogenesis of hypertension and therapeutic aspects. Circ. J. 274, 827-835.
49. Hu, L., Zhu, D. N., Yu, Z., Wang, J. Q., Sun, Z. J., and Yao, T. (2002). Expression of angiotensin type 1 (AT1) receptor in the rostral ventrolateral medulla in rats. J. Appl. Physiol. 92,2153-2161.
50. Huang, B. S., Amin, S., and Leenen, F. H. H. (2006). The central role of the brain in salt-sensitive hypertension. Curr. Opin. Cardiol. 21, 295-304.
51. Huang, B. S., and Leenen, F. H. H. (2009). The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr. Heart Fail. Rep. 6,81-88.
52. Huang, B. S., Zheng, H., Tan, J., Patel, K. P., and Leenen, F. H. H. (2011). Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone. Exp. Physiol. 96, 1028-1038.
53. Infanger, D. W., Shrama, R. V., and Davisson, R. L. (2006). NADPH oxidases of the brain: distribution, regulation, and function. Antioxid. Redox Signal. 8, 1583-1596.
54. Iwanami, J., Mogi, M., Iwai, M., and Horiuchi, M. (2009). Inhibition of the renin-angiotensin system and target organ protection. Hypertens. Res. 32, 229-237.
55. Kimura, Y., Hirooka, Y., Kishi, T., Ito, K., Sagara, Y., and Sunagawa, K. (2009). Role of inducible nitric oxide synthase in rostral ventrolateral medulla in blood pressure regulation in spontaneously hypertensive rats. Clin. Exp. Hypertens. 31, 281-286.
56. Kimura, Y., Hirooka, Y., Sagara, Y., Ito, K., Kishi, T., Shimokawa, H., Takeshita, A., and Sunagawa, K. (2005). Overexpression of inducible nitric oxide synthase in rostral ven-trolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ. Res. 96, 252-260.
57. Kishi, T., and Hirooka, Y. (2010). Sympathoinhibitory effects of ator-vastatin in hypertension. Circ. J. 74, 2552-2553.
58. Kishi, T., Hirooka, Y., Ito, K., Sakai, K., Shimokawa, H., and Takeshita, A. (2002). Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 39, 264-268.
59. Kishi, T., Hirooka, Y., Katsuki, M., Ogawa, K., Shinohara, K., Isegawa, K., and Sunagawa, K. (2012a). Exercise training causes sympa-thoinhibition through antioxidant effect in the rostral ventrolateral medulla of hypertensive rats. Clin. Exp. Hypertens. 34, 278-283.
60. Kishi, T., Hirooka, Y., and Sunagawa, K. (2012b). Sympathoinhibition caused by orally administered telmisartan through inhibition of AT(1) receptor in the rostral ventrolateral medulla. Hypertens. Res. doi: 10.1038/hr.2012.63. [Epub ahead of print].
61. Kishi, T., Hirooka, Y., Kimura, Y., Ito, K., Shimokawa, H., and Takeshita, A. (2004). Increased reactive oxygen species in rostral ventrolateral medulla contributes to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109, 2357-2362.
62. Kishi, T., Hirooka, Y., Konno, S., Ogawa, K., and Sunagawa, K. (2010a). Angiotensin II type 1 receptor activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 55, 291-297.
63. Kishi, T., Hirooka, Y., Konno, S., and Sunagawa, K. (2010b). Sympathoinhibition induced by centrally administered atorvastatin is associated with alteration of NAD(P)H oxidase and Mn superoxide dismutase activity in rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 55,184-190.
64. Kishi, T., Hirooka, Y., and Sunagawa, K. (2010c). Autoimplantation of astro-cytes into cardiovascular center of brainstem causes sympathoinhibition and decreases the mortality rate in hypertensive rats. Circulation 122, A13856.
65. Kishi, T., Hirooka, Y., Konno, S., and Sunagawa, K. (2009). Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP. Clin. Exp. Hypertens. 31, 698-704.
66. Kishi, T., Hirooka, Y., Mukai, Y., Shimokawa, H., and Takeshita, A. (2003). Atorvastatin causes depressor and sympathoinhibitory effects with upregulation of nitric oxide synthase in stroke-prone spontaneously hypertensive rats. J. Hypertens. 21, 379-386.
67. Kishi, T., Hirooka, Y., Ogawa, K., Konno, S., and Sunagawa, K. (2011a). Calorie restriction inhibits sympathetic nerve activity via anti-oxidant effect in the rostral ventrolateral medulla of obesity-induced hypertensive rats. Clin. Exp. Hypertens. 33, 240-245.
68. Kishi, T., Hirooka, Y., and Sunagawa, K. (2011b). Autoimplantation of astrocytes into the cardiovascular center of brainstem causes sympathoinhibition and decreases the mortality rate in myocardial infarction-induced heart failure. Circulation 124, A1 1489.
69. Kishi, T., Hirooka, Y., Sakai, K., Shigematsu, H., Shimokawa, H., and Takeshita, A. (2001). Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 38, 896-901.
70. Kishi, T., Hirooka, Y., Shimokawa, H., Takeshita, A., and Sunagawa, K. (2008). Atorvastatin reduced oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 30,3-11.
71. Kishi, T., and Sunagawa, K. (2011). Experimental 'jet lag' causes sympathoexcitation via oxidative stress through AT1 receptor in the brainstem. Conf. Proc. IEEE Eng. Med. Biol.Soc.2011, 1969-1972.
72. Kishi, T., and Sunagawa, K. (2012). Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats. Circ. J. 76, 1934-1941.
73. Koga, Y., Hirooka, Y., Araki, S., Nozoe, M., Kishi, T., and Sunagawa, K. (2008). High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens. Res. 31,2075-2083.
74. Konno, S., Hirooka, Y., Araki, S., Koga, Y., Kishi, T., and Sunagawa, K. (2008). Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 52, 555-560.
75. Konno, S., Hirooka, Y., Kishi, T., and Sunagawa, K. (2012). Sympathoinhibitory effect of telmisartan through the reduction of oxidative stress in rostral ventrolateral medulla of obesity-induced hypertensive rat. J. Hypertens. [Epub ahead of print].
76. Krum, H., Schlaich, M. P., Whitbourn, R., Sobotka, P., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., Abraham, W. T., and Esler, M. (2009). Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of principle cohort study. Lancet 373, 1275-1281.
77. Kung, L. C., Chan, S. H., Wu, K. L., Ou, C. C., Tai, M. H., and Chan, J. Y. (2008). Mitochondrial respiratory enzyme complexes in rostral ventrolateral medulla as cellular targets of nitric oxide and superoxide interaction in the antagonism of antihyper-tensive action of eNOS transgene. Mol. Pharmacol. 74, 1319-1332.
78. Landsberg, L. (2001). Insulin-mediated sympathetic stimulation: role in the pathogenesis ofobesity-related hypertension (or, how insulin affects blood pressure, and why). J. Hypertens. 19, 523-528.
79. Leenen, F. H. H. (2007). Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ. Res. 101,221-223.
80. Leenen, F. H. H., and Yuan, B. (2001). Prevention of hypertension by irbe-sartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade. Hypertension 37, 981-984.
81. Li, D. P., Chen, S. R., and Pan, H. L. (2002). Nitric oxide inhibits spinally projecting paraventricular neurons through potentiation of presynaptic GABA release. J. Neurophysiol. 88, 2664-2674.
82. Lin, Y., Matsumura, K., Kagiyama, S., Fukuhara, M., Fujii, K., and Iida, M. (2005). Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR. Brain Res. 1058, 161-166.
83. Liu, D., Gao, L., Roy, S. K., Cornish, K. G., and Zucker, I. H. (2006). Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein [1] and Jun N-terminal kinase. Circ. Res. 99, 1004-1011.
84. Mauo, K., Lambert, G. W., Esler, M. D., Rakugi, H., Ogihara, T., and Schlaich, M. P. (2010). The role of sympathetic nervous system activity in renal injury and end-stage renal disease. Hypertens. Res. 33, 521-528.
85. McKinley, M. J., Albiston, A. L., Allen, A. M., Mathai, M. L., May, C. N., McAllen, R. M., Oldfield, B. J., Mendelsohn, F. A. O., and Chai, S. Y. (2003). The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 35, 901-918.
86. Mogi, M., and Horiuchi, M. (2009). Effects of angiotensin II receptor blockers on dementia. Hypertens. Res. 32, 738-740.
87. Mu, S., Shimosawa, T., Ogura, S., Wang, H., Uetake, Y., Kawakami-Mori, F., Marumo, T., Yatomi, Y., Geller, D. S., Tanaka, H., and Fujita, T. (201 1).Epigenetic modulation on the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat. Med. 17, 573-580.
88. Nagae, A., Fujita, M., Kawarazaki, H., Matsui, H., Ando, K., and Fujita, T. (2009). Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 119,978-986.
89. Nishihara, M., Hirooka, Y., Matsukawa, R., Kishi, T., and Sunagawa, K. (2012). Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J. Hypertens. 30, 97-106.
90. Nishimura, Y., Ito, T., Hoe, K. L., and Saavedra, J. M. (2000). Chronic peripheral administration of the angiotensin II AT1 receptor antagonist candesartan blocks brain AT1 receptors. Brain Res. 871, 29-38.
91. Nozoe, M., Hirooka, Y., Koga, Y., Araki, S., Konno, S., Kishi, T., Ide, T., and Sunagawa, K. (2008). Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J. Hypertens. 26, 2176-2184.
92. Nozoe, M., Hirooka, Y., Koga, Y., Sagara, Y., Kishi, T., Engelhardt, J. F., and Sunagawa, K. (2007). Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart arte in stroke-prone spontaneously hypertensive rats. Hypertension 50, 62-68.
93. Oliveira-Sales, E. B., Colombari, D. S. A., Davisson, R. L., Kasparov, S., Hirata, A. E., Campos, R. R., and Paton, J. F. R. (2010a). Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 56, 290-296.
94. Oliveira-Sales, E. B., Nishi, E. E., Boim, M. A., Dolnikoff, M. S., Bergamaschi, C. T., and Campos, R. R. (2010b). Upregulation of AT1R and iNOS in the rostral ventrolateral medulla (RVLM) is essential for the sympathetic hyperactivity and hypertension in the 2K-1C Wistar rat model. Am. J. Hypertens. 23, 708-715.
95. Oliveira-Sales, E. B., Dugaich, A. P., Carillo, B. A., Abreu, N. P., Boim, M. A., Martins, P. J., D'Ameida, V., Dolnkoff, M. S., Bergamaschi, C. T., and Campos, R. R. (2008). Oxidative stress contributes to renovascular hypertension. Am. I Hypertens. 21,98-104.
96. Oliveira-Sales, E. B., Nishi, E. E., Carillo, B. A., Dolnikoff, M. S., Bergamaschi, C. T., and Campos, R. R. (2009). Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am. I Hypertens. 22, 484-492.
97. Osborn, J. W., Fink, G. D., Sved, A. E, Toney, G. M., and Raizada, M. K. (2007). Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr. Hypertens. Rep. 9, 228-235.
98. Patel, K., Li, Y. F., and Hirooka, Y. (2001). Role of nitric oxide in central sympathetic outflow. Exp. Biol. Med. 226,814-824.
99. Peterson, J. R., Sharma, R. V., and Davisson, R. L. (2006). Reactive oxygen species in the neuropatho-genesis of hypertension. Curr. Hypertens. Rep. 8, 232-241.
100. Pilowsky, P. M., and Goodchild, A. K. (2002). Baroreceptor reflex pathways and neurotransmitters: 10 years on. J. Hypertens. 20, 1675-1688.
101. Pliquett, R. U., Comish, K. G., and Zucker, I. H. (2003). Statin therapy restores sympathovagal balance in experimental heart failure. J. Appl. Physiol. 95, 700-704.
102. Prior, L. J., Eikelis, N., Armitage, J. A., Davern, P. J., Burke, S. L., Montani, J. P., Barzel, B., and Head, G. A. (2010). Exposure to a high-fat diet alters leptin sensi-tivityand elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55, 862-868.
103. Rahmouni, K., Correia, M. L., Haynes, W. G., and Mark, A. L. (2005). Obesity-associated hypertension: new insights into mechanisms. Hypertension 45, 9-14.
104. Reja, V., Goodchild, A. K., Phillips, J. K., and Pilowsky, P. M. (2006). Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin. Exp. Pharmacol Physiol. 33, 690-695.
105. Shi, P., Diez-Freire, C., Jun, J. Y., Qi, Y., Katovich, M. J., Li, Q., Sriramula, S., Francis, J., Summers, C., and Raizada, M. K. (2010). Brain microglial cytokines in neurogenic hypertension. Hypertension 56, 297-303.
106. Shinohara, K., Hirooka, Y., Ogawa, K., Kishi, T., Yasukawa, K., Utsumi, H., and Sunagawa, K. (2012). Combination therapy of olme-sartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive rats. Clin. Exp. Hypertens. doi: 10.3109/10641963. 2012.666603. [Epub ahead of print].
107. Siddiqi, L., Joles, J. A., Oey, P. L., and Blankestijn, P. J. (2011). Atorvastatin reduced sympathetic activity in patients with chronic kidney disease. J. Hypertens. 29, 2176-2180.
108. Simplicity HTN-2 Investigators. (2010). Renal sympathetic dener-vation in patients with treatment-resistant hypertension (the simplicity HTN-2 trail): a randomized controlled trial. Lancet 376, 1903-1909.
109. Sinski, M., Lewandowsk, J., Ciarka, A., Bidiuk, J., Abramczyk, P., Dobosiewicz, A., and Gaciong, Z. (2009). Atorvastatin reduced sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolemia and systemic arterial hypertension. Kardiol Pol. 67, 613-620.
110. Stella, A., Golin, R., Genovesi, S., and Zanchetti, A. (1987). Renal reflexes in the regulation of blood pressure and sodium excretion. Can. J. Physiol Pharmacol. 65, 1536-1539.
111. Stocker, S. D., Meador, R., and Adams, J. M. (2007). Neurons of the rostral ventrolateral medullacontribute to obesity-induced hypertension in rats. Hypertension 49, 640-646.
112. Sun, J., Druhan, L. J., and Zweler, J. L. (2010). Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and super-oxide production. Arch. Biochem. Biophys. 494, 130-137.
113. Sved, A. F., Ito, S., and Sved, J. C. (2003). Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr. Hypertens. Rep. 5, 262-268.
114. Tai, M. H., Wang, L. L., Wu, K. L. H., and Chan, J. Y H. (2005). Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide. Free Rad. Biol. Med. 38, 450-462.
115. Tsuchihashi, T., Kagiyama, S., Matsumura, K., Abe, I., and Fujishima, M. (1999). Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR. J. Hypertens. 17,917-922.
116. Umemoto, S., Tanaka, M., Kawahara, S., Kubo, M., Umeji, K., Hashimoto, R., and Matsuzaki, M. (2004). Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hyper-tensiverats. Hypertens. Res. 27, 877-885.
117. Wang, G., Anrather, J., Huang, J., Speth, R. C., Pickel, V. M., and Iadecola, C. (2004). NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J. Neurosci. 24, 5516-5524.
118. Wang, G., Anrather, J., Glass, M. J., Tarsitano, J., Zhou, P., Frys, K. A., Pickel, V. M., and Iadecola, C. (2006). Nox2, Ca2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48, 482-489.
119. 1 receptor blockers.J. Cardiovasc. Pharmacol. 41, 593-599.
120. Wassmann, S., Laufs, U., Muller, K., Konkol, C., Ahlbory, K., Baumer, A. T., Linz, W., Bohm, M., and Nickenig, G. (2002). Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 22, 300-305.
121. Ye, S., Zhong, H., and Campese, V. M. (2006). Oxidative stress mediates the sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 48, 309-315.
122. Yu, Y., Zhang, Z. H., Wei, S. G., Serrats, J., Weiss, R. M., and Felder, R. B. (2010). Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction. Hypertension 55, 652-659.
123. Zanzinger, J. (2002). Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton. Neurosci. 98, 24-27.
124. Zielonka, J., Zielonka, M., Sikora, A., Adamus, J., Joseph, J., Hardy, M., Ouari, O., Dranka, B. P., and Kalyanaraman, B. (2012). Global profiling of reactive oxygen and nitrogen species in biological systems: high-throughput realtime analysis. J. Biol Chem. 287, 2984-2995.
125. Zimmerman, M. C., Dunlay, R. P., Lazartigues, E., Zhang, Y., Sharma, R. V., Engelhardt, J. E, and Davisson, R. L. (2004a). Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95, 532-539.
126. Zimmerman, M. C., Larzartigues, E., Shrama, R. V., and Davisson, R. L. (2004b). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 95,210-216.
127. Zimmerman, M. C., and Zucker, I. H. (2009). Mitochondrial dysfunction and mitochondria-produced reactive oxygen species: new aspects for neurogenic hypertension? Hypertension. 53, 112-114.
128. Zucker, I. H., Schultz, H. D., Patel, K. P., Wang, W., and Gao, L. (2009). Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am. J. Physiol. 297, H1557-H1566.